648 related articles for article (PubMed ID: 25940933)
1. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
Bhatt V; Pillai R
J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
[TBL] [Abstract][Full Text] [Related]
2. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
[TBL] [Abstract][Full Text] [Related]
3. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
Kircik LH
J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
[TBL] [Abstract][Full Text] [Related]
4. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
Gupta AK; Pillai R
J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
[TBL] [Abstract][Full Text] [Related]
5. Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space.
Elewski BE; Pollak RA; Pillai R; Olin JT
J Drugs Dermatol; 2014 Nov; 13(11):1394-8. PubMed ID: 25607708
[TBL] [Abstract][Full Text] [Related]
6. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
7. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
Pollak RA
J Am Podiatr Med Assoc; 2014 Nov; 104(6):568-73. PubMed ID: 25514267
[TBL] [Abstract][Full Text] [Related]
8. Efinaconazole 10% nail solution: a new topical treatment with broad antifungal activity for onychomycosis monotherapy.
Gupta AK; Paquet M
J Cutan Med Surg; 2014; 18(3):151-5. PubMed ID: 24800702
[TBL] [Abstract][Full Text] [Related]
9. Efinaconazole 10% and Tavaborole 5% Penetrate Across Poly-ureaurethane 16%: Results of In Vitro Release Testing and Clinical Implications of Onychodystrophy in Onychomycosis.
Adigun CG; Vlahovic TC; McClellan MB; Thakker KD; Klein RR; Elstrom TA; Ward DB
J Drugs Dermatol; 2016 Sep; 15(9):1116-20. PubMed ID: 27602975
[TBL] [Abstract][Full Text] [Related]
10. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
Lipner SR; Scher RK
Expert Rev Clin Pharmacol; 2015; 8(6):719-31. PubMed ID: 26325488
[TBL] [Abstract][Full Text] [Related]
11. Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
Tschen EH; Bucko AD; Oizumi N; Kawabata H; Olin JT; Pillai R
J Drugs Dermatol; 2013 Feb; 12(2):186-92. PubMed ID: 23377392
[TBL] [Abstract][Full Text] [Related]
12. Efinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis.
Tosti A
Cutis; 2013 Oct; 92(4):203-8. PubMed ID: 24195094
[TBL] [Abstract][Full Text] [Related]
13. Preparation and
Lee BC; Pangeni R; Na J; Koo KT; Park JW
Drug Deliv; 2019 Dec; 26(1):1167-1177. PubMed ID: 31738083
[TBL] [Abstract][Full Text] [Related]
14. Insights into drug delivery across the nail plate barrier.
Saner MV; Kulkarni AD; Pardeshi CV
J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
[TBL] [Abstract][Full Text] [Related]
15. Efinaconazole topical solution 10%: Formulation and efficacy assessment in the treatment of toenail onychomycosis.
Naeimifar A; Samadi A; Ahmad Nasrollahi S; Fattahi A; Ghasemi Z; Azizzadeh-Roodpishi S; Malakooti S; Ehsani AH; Firooz A; Dowlatiy Y
Mycoses; 2020 May; 63(5):517-524. PubMed ID: 32048351
[TBL] [Abstract][Full Text] [Related]
16. Transungual delivery of ketoconazole using novel lacquer formulation.
Hafeez F; Hui X; Chiang A; Hornby S; Maibach H
Int J Pharm; 2013 Nov; 456(2):357-61. PubMed ID: 24029171
[TBL] [Abstract][Full Text] [Related]
17. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
Elewski BE; Rich P; Pollak R; Pariser DM; Watanabe S; Senda H; Ieda C; Smith K; Pillai R; Ramakrishna T; Olin JT
J Am Acad Dermatol; 2013 Apr; 68(4):600-608. PubMed ID: 23177180
[TBL] [Abstract][Full Text] [Related]
18. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
Sugiura K; Sugimoto N; Hosaka S; Katafuchi-Nagashima M; Arakawa Y; Tatsumi Y; Jo Siu W; Pillai R
Antimicrob Agents Chemother; 2014 Jul; 58(7):3837-42. PubMed ID: 24752277
[TBL] [Abstract][Full Text] [Related]
19. Rapid Treatment of Subungual Onychomycosis Using Controlled Micro Nail Penetration and Terbinafine Solution.
Bristow I; Baran R; Score M
J Drugs Dermatol; 2016 Aug; 15(8):974-8. PubMed ID: 27537998
[TBL] [Abstract][Full Text] [Related]
20. Ungual and transungual drug delivery.
Shivakumar HN; Juluri A; Desai BG; Murthy SN
Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
